U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Lucid Diagnostics Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 82-5488042 | |
|
(State of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
|
One Grand Central Place, Suite 4600 New York, New York |
10165 | |
| (Address of Principal Executive Offices) | (Zip Code) |
| If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. ☒ | If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ☐ |
| Securities Act registration statement file number to which this form relates: | 333-259721 |
| (If applicable) |
| Securities to be registered pursuant to Section 12(b) of the Act: |
|
Title of Each Class to be Registered |
Name of Each Exchange on Which Each Class is to be Registered |
|
| Common stock, par value $0.001 per share | The Nasdaq Stock Market LLC |
Securities to be registered pursuant to Section 12(g) of the Act:
| None |
| (Title of Class) |
Item 1. Description of Registrant’s Securities to be Registered.
The security to be registered hereby is the common stock of Lucid Diagnostics Inc. (the “Company”). The description of the common stock contained under the heading “Description of Common Stock” in the registration statement initially filed with the Securities and Exchange Commission on September 22, 2021, as amended from time to time (File No. 333-259721) (the “Registration Statement”) to which this Form 8-A relates is incorporated herein by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that are subsequently filed are hereby also incorporated by reference herein.
Item 2. Index to Exhibits.
Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed because no other securities of the Company are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934.
| 1 |
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
| LUCID DIAGNOSTICS INC. | ||
| Date: October 12, 2021 | By: | /s/ Lishan Aklog, M.D. |
| Lishan Aklog, M.D. | ||
| Chairman | ||
| 2 |